Conference Coverage

PSYCHIATRY UPDATE 2017


 

Luncheon Symposium

Depression, Its impact, and the Importance of Recognition and Treatment


Faculty: Jon Winston Draud, MS, MD, University of Tennessee Health Science Center

Major depressive disorder (MDD) is the most commonly diagnosed condition, second to cardiovascular disease. Dr. Draud recommended using a wellness screen such as the WHO-5 (World Health Organization, 5 item well-being index) in addition to a depression screening tool such as the PHQ-9. He emphasized that the goal of treatment should not be merely remission—but remission without residual symptoms. Cognitive impairment is the most common residual symptom. Patients with residual symptoms relapse earlier (5.5 times faster) and at a greater rate than patients without residual symptoms (76% vs 25%, respectively). Continue treatment and monitoring even after symptoms appear to subside. Recommended treatment is multi-modal and should include cognitive therapy and exercise.

Pages

Recommended Reading

Risk considerations for suicidal physicians
MDedge Psychiatry
Ask patients about sexual function at first visit
MDedge Psychiatry
Depression and deep brain stimulation: ‘Furor therapeuticus redux’
MDedge Psychiatry
APA task force urges caution in off-label use of ketamine for mood disorders
MDedge Psychiatry
Managing family differences
MDedge Psychiatry
Are new medications on horizon for patients with depression, inflammation?
MDedge Psychiatry
Spousal suicide linked to higher risk of mental, physical disorders
MDedge Psychiatry
Anxiety in children during a new administration; Why medical psychiatry is vital for my patients; And more
MDedge Psychiatry
SPECT reveals perfusion problems in antiphospholipid syndrome
MDedge Psychiatry
In type 2 diabetes, chronotype may affect depressive symptoms
MDedge Psychiatry